Cargando…
Pro-Inflammatory versus Immunomodulatory Effects of Silver Nanoparticles in the Lung: The Critical Role of Dose, Size and Surface Modification
The growing use of silver nanoparticles (Ag-NPs) in consumer products raises concerns about their toxicological potential. The purpose of the study was to investigate the size- and coating-dependent pulmonary toxicity of Ag-NPs in vitro and in vivo, using an ovalbumin (OVA)-mouse allergy model. Supe...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666465/ https://www.ncbi.nlm.nih.gov/pubmed/28961222 http://dx.doi.org/10.3390/nano7100300 |
_version_ | 1783275319698915328 |
---|---|
author | Alessandrini, Francesca Vennemann, Antje Gschwendtner, Silvia Neumann, Avidan U. Rothballer, Michael Seher, Tanja Wimmer, Maria Kublik, Susanne Traidl-Hoffmann, Claudia Schloter, Michael Wiemann, Martin Schmidt-Weber, Carsten B. |
author_facet | Alessandrini, Francesca Vennemann, Antje Gschwendtner, Silvia Neumann, Avidan U. Rothballer, Michael Seher, Tanja Wimmer, Maria Kublik, Susanne Traidl-Hoffmann, Claudia Schloter, Michael Wiemann, Martin Schmidt-Weber, Carsten B. |
author_sort | Alessandrini, Francesca |
collection | PubMed |
description | The growing use of silver nanoparticles (Ag-NPs) in consumer products raises concerns about their toxicological potential. The purpose of the study was to investigate the size- and coating-dependent pulmonary toxicity of Ag-NPs in vitro and in vivo, using an ovalbumin (OVA)-mouse allergy model. Supernatants from (5.6–45 µg/mL) Ag50-PVP, Ag200-PVP or Ag50-citrate-treated NR8383 alveolar macrophages were tested for lactate dehydrogenase and glucuronidase activity, tumor necrosis factor (TNF)-α release and reactive oxygen species (ROS) production. For the in vivo study, NPs were intratracheally instilled in non-sensitized (NS) and OVA-sensitized (S) mice (1–50 µg/mouse) prior to OVA-challenge and bronchoalveolar lavage fluid (BALF) inflammatory infiltrate was evaluated five days after challenge. In vitro results showed a dose-dependent cytotoxicity of Ag-NPs, which was highest for Ag50-polyvinilpyrrolidone (PVP), followed by Ag50-citrate, and lowest for Ag200-PVP. In vivo 10–50 µg Ag50-PVP triggered a dose-dependent pulmonary inflammatory milieu in NS and S mice, which was significantly higher in S mice and was dampened upon instillation of Ag200-PVP. Surprisingly, instillation of 1 µg Ag50-PVP significantly reduced OVA-induced inflammatory infiltrate in S mice and had no adverse effect in NS mice. Ag50-citrate showed similar beneficial effects at low concentrations and attenuated pro-inflammatory effects at high concentrations. The lung microbiome was altered by NPs instillation dependent on coating and/or mouse batch, showing the most pronounced effects upon instillation of 50 µg Ag50-citrate, which caused an increased abundance of operational taxonomic units assigned to Actinobacteria, Bacteroidetes, Firmicutes and Proteobacteria. However, no correlation with the biphasic effect of low and high Ag-NPs dose was found. Altogether, both in vitro and in vivo data on the pulmonary effects of Ag-NPs suggest the critical role of the size, dose and surface functionalization of Ag-NPs, especially in susceptible allergic individuals. From the perspective of occupational health, care should be taken by the production of Ag-NPs-containing consumer products. |
format | Online Article Text |
id | pubmed-5666465 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-56664652017-11-09 Pro-Inflammatory versus Immunomodulatory Effects of Silver Nanoparticles in the Lung: The Critical Role of Dose, Size and Surface Modification Alessandrini, Francesca Vennemann, Antje Gschwendtner, Silvia Neumann, Avidan U. Rothballer, Michael Seher, Tanja Wimmer, Maria Kublik, Susanne Traidl-Hoffmann, Claudia Schloter, Michael Wiemann, Martin Schmidt-Weber, Carsten B. Nanomaterials (Basel) Article The growing use of silver nanoparticles (Ag-NPs) in consumer products raises concerns about their toxicological potential. The purpose of the study was to investigate the size- and coating-dependent pulmonary toxicity of Ag-NPs in vitro and in vivo, using an ovalbumin (OVA)-mouse allergy model. Supernatants from (5.6–45 µg/mL) Ag50-PVP, Ag200-PVP or Ag50-citrate-treated NR8383 alveolar macrophages were tested for lactate dehydrogenase and glucuronidase activity, tumor necrosis factor (TNF)-α release and reactive oxygen species (ROS) production. For the in vivo study, NPs were intratracheally instilled in non-sensitized (NS) and OVA-sensitized (S) mice (1–50 µg/mouse) prior to OVA-challenge and bronchoalveolar lavage fluid (BALF) inflammatory infiltrate was evaluated five days after challenge. In vitro results showed a dose-dependent cytotoxicity of Ag-NPs, which was highest for Ag50-polyvinilpyrrolidone (PVP), followed by Ag50-citrate, and lowest for Ag200-PVP. In vivo 10–50 µg Ag50-PVP triggered a dose-dependent pulmonary inflammatory milieu in NS and S mice, which was significantly higher in S mice and was dampened upon instillation of Ag200-PVP. Surprisingly, instillation of 1 µg Ag50-PVP significantly reduced OVA-induced inflammatory infiltrate in S mice and had no adverse effect in NS mice. Ag50-citrate showed similar beneficial effects at low concentrations and attenuated pro-inflammatory effects at high concentrations. The lung microbiome was altered by NPs instillation dependent on coating and/or mouse batch, showing the most pronounced effects upon instillation of 50 µg Ag50-citrate, which caused an increased abundance of operational taxonomic units assigned to Actinobacteria, Bacteroidetes, Firmicutes and Proteobacteria. However, no correlation with the biphasic effect of low and high Ag-NPs dose was found. Altogether, both in vitro and in vivo data on the pulmonary effects of Ag-NPs suggest the critical role of the size, dose and surface functionalization of Ag-NPs, especially in susceptible allergic individuals. From the perspective of occupational health, care should be taken by the production of Ag-NPs-containing consumer products. MDPI 2017-09-29 /pmc/articles/PMC5666465/ /pubmed/28961222 http://dx.doi.org/10.3390/nano7100300 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Alessandrini, Francesca Vennemann, Antje Gschwendtner, Silvia Neumann, Avidan U. Rothballer, Michael Seher, Tanja Wimmer, Maria Kublik, Susanne Traidl-Hoffmann, Claudia Schloter, Michael Wiemann, Martin Schmidt-Weber, Carsten B. Pro-Inflammatory versus Immunomodulatory Effects of Silver Nanoparticles in the Lung: The Critical Role of Dose, Size and Surface Modification |
title | Pro-Inflammatory versus Immunomodulatory Effects of Silver Nanoparticles in the Lung: The Critical Role of Dose, Size and Surface Modification |
title_full | Pro-Inflammatory versus Immunomodulatory Effects of Silver Nanoparticles in the Lung: The Critical Role of Dose, Size and Surface Modification |
title_fullStr | Pro-Inflammatory versus Immunomodulatory Effects of Silver Nanoparticles in the Lung: The Critical Role of Dose, Size and Surface Modification |
title_full_unstemmed | Pro-Inflammatory versus Immunomodulatory Effects of Silver Nanoparticles in the Lung: The Critical Role of Dose, Size and Surface Modification |
title_short | Pro-Inflammatory versus Immunomodulatory Effects of Silver Nanoparticles in the Lung: The Critical Role of Dose, Size and Surface Modification |
title_sort | pro-inflammatory versus immunomodulatory effects of silver nanoparticles in the lung: the critical role of dose, size and surface modification |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666465/ https://www.ncbi.nlm.nih.gov/pubmed/28961222 http://dx.doi.org/10.3390/nano7100300 |
work_keys_str_mv | AT alessandrinifrancesca proinflammatoryversusimmunomodulatoryeffectsofsilvernanoparticlesinthelungthecriticalroleofdosesizeandsurfacemodification AT vennemannantje proinflammatoryversusimmunomodulatoryeffectsofsilvernanoparticlesinthelungthecriticalroleofdosesizeandsurfacemodification AT gschwendtnersilvia proinflammatoryversusimmunomodulatoryeffectsofsilvernanoparticlesinthelungthecriticalroleofdosesizeandsurfacemodification AT neumannavidanu proinflammatoryversusimmunomodulatoryeffectsofsilvernanoparticlesinthelungthecriticalroleofdosesizeandsurfacemodification AT rothballermichael proinflammatoryversusimmunomodulatoryeffectsofsilvernanoparticlesinthelungthecriticalroleofdosesizeandsurfacemodification AT sehertanja proinflammatoryversusimmunomodulatoryeffectsofsilvernanoparticlesinthelungthecriticalroleofdosesizeandsurfacemodification AT wimmermaria proinflammatoryversusimmunomodulatoryeffectsofsilvernanoparticlesinthelungthecriticalroleofdosesizeandsurfacemodification AT kubliksusanne proinflammatoryversusimmunomodulatoryeffectsofsilvernanoparticlesinthelungthecriticalroleofdosesizeandsurfacemodification AT traidlhoffmannclaudia proinflammatoryversusimmunomodulatoryeffectsofsilvernanoparticlesinthelungthecriticalroleofdosesizeandsurfacemodification AT schlotermichael proinflammatoryversusimmunomodulatoryeffectsofsilvernanoparticlesinthelungthecriticalroleofdosesizeandsurfacemodification AT wiemannmartin proinflammatoryversusimmunomodulatoryeffectsofsilvernanoparticlesinthelungthecriticalroleofdosesizeandsurfacemodification AT schmidtwebercarstenb proinflammatoryversusimmunomodulatoryeffectsofsilvernanoparticlesinthelungthecriticalroleofdosesizeandsurfacemodification |